Literature DB >> 3279156

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells.

C Heufler1, F Koch, G Schuler.   

Abstract

Freshly isolated, murine epidermal Langerhans cells (LC) are weak accessory cells for primary T cell-dependent immune responses, but increase their stimulatory capacity at least 20-fold progressively over a 3-d culture with keratinocytes. We have studied the mediators of LC maturation. LC enriched from 12-h epidermal cultures by negative selection do not survive when cultured for 60 h in standard medium. LC survive and show increased stimulatory capacity for oxidative mitogenesis and the primary MLR when 30% keratinocyte-conditioned medium is included. Of the three cytokines that are known to be produced by keratinocytes, only granulocyte/macrophage CSF (GM-CSF) maintains viability and increases stimulatory capacity. IL-1 alone does not keep LC alive, but further enhances the stimulatory activity when combined with GM-CSF. IL-3 has no effect. The increase in LC stimulatory capacity is not due to increased Ia antigen expression, which does not change between 12 and 60 h. Function is not simply due to improved viability, as GM-CSF does not enhance the function of 12-h LC when added to the short-term oxidative mitogenesis assay. By generating LC with strong stimulating activity for resting T cells, GM-CSF and IL-1 may be critical in the sensitization phase of T cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3279156      PMCID: PMC2188828          DOI: 10.1084/jem.167.2.700

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Expression of Thy-1 antigen by murine epidermal cells.

Authors:  E Tschachler; G Schuler; J Hutterer; H Leibl; K Wolff; G Stingl
Journal:  J Invest Dermatol       Date:  1983-09       Impact factor: 8.551

2.  Development and characterization of antiserum to murine granulocyte-macrophage colony-stimulating factor.

Authors:  D Y Mochizuki; J R Eisenman; P J Conlon; L S Park; D L Urdal
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

3.  Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.

Authors:  T A Luger; B M Stadler; B M Luger; B J Mathieson; M Mage; J A Schmidt; J J Oppenheim
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

4.  Identification of a novel cell type in peripheral lymphoid organs of mice. 3. Functional properties in vivo.

Authors:  R M Steinman; D S Lustig; Z A Cohn
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

5.  Cloning and expression of murine interleukin-1 cDNA in Escherichia coli.

Authors:  P T Lomedico; U Gubler; C P Hellmann; M Dukovich; J G Giri; Y C Pan; K Collier; R Semionow; A O Chua; S B Mizel
Journal:  Nature       Date:  1984 Nov 29-Dec 5       Impact factor: 49.962

6.  Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.

Authors:  M D Witmer-Pack; W Olivier; J Valinsky; G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

7.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

8.  Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes.

Authors:  K Inaba; G Schuler; M D Witmer; J Valinksy; B Atassi; R M Steinman
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

9.  Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells.

Authors:  S L Koide; K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

10.  Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1.

Authors:  T S Kupper; D W Ballard; A O Chua; J S McGuire; P M Flood; M C Horowitz; R Langdon; L Lightfoot; U Gubler
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

  10 in total
  97 in total

1.  Pattern of cytokine receptors expressed by human dendritic cells migrated from dermal explants.

Authors:  A T Larregina; A E Morelli; E Kolkowski; N Sanjuan; M E Barboza; L Fainboim
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 2.  Dynamic nature and function of epidermal Langerhans cells in vivo and in vitro: a review, with emphasis on human Langerhans cells.

Authors:  M B Teunissen
Journal:  Histochem J       Date:  1992-10

Review 3.  The immunologic properties of epidermal Langerhans cells as a part of the dendritic cell system.

Authors:  N Romani; G Schuler
Journal:  Springer Semin Immunopathol       Date:  1992

4.  Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells in vitro than Langerhans cells from skin.

Authors:  B Hasséus; M Jontell; G Bergenholtz; U I Dahlgren
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

5.  Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture.

Authors:  A Larregina; A Morelli; E Kolkowski; L Fainboim
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

6.  Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X.

Authors:  A Tazi; M Bonay; A Bergeron; M Grandsaigne; A J Hance; P Soler
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

7.  Simple chemicals can induce maturation and apoptosis of dendritic cells.

Authors:  H Manome; S Aiba; H Tagami
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

Review 8.  Cancer of the cervix: prospects for immunological control.

Authors:  D H Davies; G A McIndoe; B M Chain
Journal:  Int J Exp Pathol       Date:  1991-04       Impact factor: 1.925

Review 9.  Peptide vaccines for the treatment of glioblastoma.

Authors:  Adam M Swartz; Kristen A Batich; Peter E Fecci; John H Sampson
Journal:  J Neurooncol       Date:  2014-12-10       Impact factor: 4.130

10.  CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

Authors:  A A Hurwitz; T F Yu; D R Leach; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.